NCT00333125View on ClinicalTrials.gov

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 40 mcg/ml + Timolol 5 mg/ml eye drops, solution (DuoTrav)

One drop in the study eye(s) once daily, 9 PM, for 6 weeks

DRUG

Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (Cosopt)

One drop in the study eye(s) twice daily for 6 weeks

OTHER

Timolol Vehicle

One drop in the study eye(s) once daily for 6 weeks

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY